secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001683168-25-001137
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio Pharmaceuticals appoints David H. Deming to Board of Directors, effective Feb 19, 2025
--------------------------------------------------------------------------------

- Board expanded to six members; five of six are independent directors.
- Deming will serve on the Nominating Committee immediately.
- Over 30 years in investment banking; 27 years at JP Morgan leading Health Group in M&A.
- Appointment effective February 19, 2025; term until 2025 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825001137/0001683168-25-001137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825001137/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-001137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer